Images
Participants
Contact
The Genetic Engineering & Biotechnology News (GEN) magazine and other media have echoed an article recently published in the Journal of the American Chemical Society (JACS) by a group of scientists led by Modesto Orozco, Group Leader at IRB Barcelona, Director of Life Sciences at the BSC-CNS, and Professor at the UB. Comprising researchers from IRB Barcelona, the University of Cambridge, and the University of New York, this group has discovered the molecular mechanism by which a type of epigenetic markers influence gene expression.
Read the article in GEN
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
